A study of RFA which performed to the Hepatocellular carcinoma with affixing return electrode to a back

A study of RFA which performed to the Hepatocellular carcinoma with affixing return electrode to a back - RFA with affixing return electrode to a back

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013331

Enrollment

100

Registered

2014-04-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellilar carcinoma

Interventions

group A: with affixing return electrode to both thighs group B: with affixing return electrode to a back

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)the case who was diagnosed hepatocellular carcinoma by biopsy or clinical diagnosis 2)the case adapted the following item WBC > 1000/mm3 Plt > 50000/mm3 Hb > 8.5g/dL T.Bil < 3.0mg/dL Cr < 1.5mg/dL AST < 380IU/L ALT < 350IU/L PT(%) > 40%

Exclusion criteria

Exclusion criteria: 1) The case who cannot reply by any modality 2) The case who have severe complication without chronic hepatitis and liver cirrhosis 3) The case who have severe hypersensitivity 4) The case who is or may be pregnant and is nursing 5) The case who was judged with inadequacy by the doctor

Design outcomes

Primary

Measure	Time frame
Ablation time to complete RFA Arrival temperature Complications Selection of Cool-tip needles VAS scale	—

Secondary

Measure	Time frame
WBC, RBC, Hb, Ht, Plt, TP, Alb, AST, ALT, ALP, gamma-GTP, Cr, CRP and BS one day after RFA maximal ablation diameter x minimal ablation diameter by CT one day after RFA	—

Countries

Japan

Contacts

Public ContactKazuya Kariyama

Okayama City Hospital Department of liver disease center

kariyama777@gmail.com086-225-3171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026